4 Stock Recommendations for May 28 to June 01, 2018
1) RBL Bank Limited - BUY
Stock Pick
|
Observation
| |
Company
|
RBL Bank Limited
|
|
Recommendation
| ||
Buy or Sell
|
Buy (Cash)
| |
Range (Rs)
|
512-517
| |
Target (Rs)
|
552
| |
Stop Loss (Rs)
|
492
| |
Duration
|
1 week
| |
200 D-EMA
|
499
| |
NSE Code
|
RBLBANK
|

2) Kotak Mahindra Bank Limited - BUY
Stock Pick
|
Observation
| |
Company
|
Kotak Mahindra Bank Limited
|
|
Recommendation
| ||
Buy or Sell
|
Buy (Cash)
| |
Range (Rs)
|
1,288-1,298
| |
Target (Rs)
|
1,370
| |
Stop Loss (Rs)
|
1,240
| |
Duration
|
1 week
| |
200 D-EMA
|
1071
| |
NSE Code
|
KOTAKBANK
|

3) Tata Sponge Iron Limited - BUY
Stock Pick
|
Observation
| |
Company
|
Tata Sponge Iron Limited
|
|
Recommendation
| ||
Buy or Sell
|
Buy (Cash)
| |
Range (Rs)
|
1,089-1,098
| |
Target (Rs)
|
1,170
| |
Stop Loss (Rs)
|
1,046
| |
Duration
|
1 week
| |
200 D-EMA
|
980
| |
NSE Code
|
TATASPONGE
|

4. Stock Name - UPL Ltd - BUY
CMP: 697, Upside: 24%, Period: 1 Year
UPL is a leading global generic agrochemicals player engaged in the production of crop protection products, intermediates, specialty chemicals and other industrial chemicals. Its geographical revenue mix in FY18 consisted of Latin America (~33%), India (~18%), North America (~18%) and Europe (~13%). Rest of the world contributed ~18% to its revenue in FY18. UPL’s export opportunities are increasing owing to low cost manufacturing base providing diversified geographical reach across key markets in the world. UPL plans to launch new products in fungicide and herbicide segments in India, which are expected to grow by 15% over next 5 years supported by good monsoon. Rising input costs may drive agrochemical prices higher if demand recovers enabling margin improvement through backward integration. Overall, we see revenue CAGR of ~13% over FY18-20E. We expect expansion in EBITDA margin by ~50bps over FY18-20E (20.7% in FY20E). Further, we expect the company to reduce D/E ratio to ~0.3x in FY20E (~0.9x in FY17). Consequently, we estimate PAT CAGR of ~20% over FY18-20E. We recommend BUY on the stock with target valuation at 15x FY20E EPS.
No comments